Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Catheter Ablation | 55 | 2024 | 2751 | 3.400 |
Why?
|
Defibrillators, Implantable | 17 | 2024 | 1492 | 2.640 |
Why?
|
Tachycardia, Ventricular | 32 | 2023 | 1305 | 2.160 |
Why?
|
Arrhythmias, Cardiac | 15 | 2023 | 2247 | 1.590 |
Why?
|
Pacemaker, Artificial | 8 | 2024 | 807 | 1.560 |
Why?
|
Atrial Fibrillation | 19 | 2024 | 5114 | 1.510 |
Why?
|
Tachycardia, Ectopic Atrial | 4 | 2022 | 65 | 1.370 |
Why?
|
Electrophysiologic Techniques, Cardiac | 18 | 2024 | 507 | 0.910 |
Why?
|
Tachycardia, Sinus | 2 | 2017 | 43 | 0.810 |
Why?
|
Cardiomyopathies | 10 | 2022 | 2021 | 0.800 |
Why?
|
Cardiac Resynchronization Therapy | 6 | 2024 | 558 | 0.790 |
Why?
|
Anti-Arrhythmia Agents | 10 | 2018 | 774 | 0.780 |
Why?
|
Anesthesia, Local | 1 | 2024 | 277 | 0.780 |
Why?
|
Tachycardia, Supraventricular | 2 | 2022 | 273 | 0.760 |
Why?
|
Electrocardiography | 25 | 2024 | 6387 | 0.700 |
Why?
|
Cardiac Pacing, Artificial | 7 | 2015 | 866 | 0.590 |
Why?
|
Electric Countershock | 2 | 2018 | 533 | 0.570 |
Why?
|
Sinoatrial Node | 1 | 2017 | 99 | 0.560 |
Why?
|
Death, Sudden, Cardiac | 6 | 2018 | 1560 | 0.550 |
Why?
|
Benzazepines | 1 | 2017 | 310 | 0.490 |
Why?
|
Heart Transplantation | 6 | 2017 | 3258 | 0.470 |
Why?
|
Atrial Flutter | 4 | 2017 | 252 | 0.450 |
Why?
|
Pericardium | 5 | 2023 | 674 | 0.440 |
Why?
|
Heart Failure | 12 | 2024 | 11701 | 0.440 |
Why?
|
Stroke Volume | 10 | 2024 | 5521 | 0.430 |
Why?
|
Magnetic Resonance Imaging, Cine | 2 | 2018 | 1061 | 0.420 |
Why?
|
Cardiomyopathy, Dilated | 2 | 2018 | 832 | 0.420 |
Why?
|
Equipment Failure Analysis | 2 | 2014 | 846 | 0.390 |
Why?
|
Ventricular Fibrillation | 3 | 2022 | 537 | 0.380 |
Why?
|
Body Surface Potential Mapping | 4 | 2010 | 228 | 0.380 |
Why?
|
Bundle-Branch Block | 4 | 2024 | 277 | 0.380 |
Why?
|
Electrodes, Implanted | 4 | 2014 | 839 | 0.370 |
Why?
|
Renal Dialysis | 5 | 2022 | 1796 | 0.370 |
Why?
|
Heart Ventricles | 11 | 2023 | 3813 | 0.360 |
Why?
|
Heart Rate | 8 | 2024 | 4197 | 0.360 |
Why?
|
Primary Prevention | 1 | 2018 | 1185 | 0.360 |
Why?
|
Ventricular Function, Left | 4 | 2023 | 3899 | 0.340 |
Why?
|
Tachycardia | 3 | 2022 | 599 | 0.340 |
Why?
|
Wolff-Parkinson-White Syndrome | 1 | 2010 | 116 | 0.340 |
Why?
|
Spouses | 1 | 2011 | 284 | 0.310 |
Why?
|
Treatment Outcome | 35 | 2024 | 64681 | 0.300 |
Why?
|
Tachycardia, Atrioventricular Nodal Reentry | 3 | 2015 | 148 | 0.300 |
Why?
|
Electrocardiography, Ambulatory | 3 | 2019 | 577 | 0.290 |
Why?
|
Heart Injuries | 3 | 2023 | 206 | 0.290 |
Why?
|
Adrenergic Antagonists | 1 | 2007 | 26 | 0.290 |
Why?
|
Heart Conduction System | 5 | 2023 | 1008 | 0.290 |
Why?
|
Postoperative Complications | 10 | 2018 | 15637 | 0.290 |
Why?
|
Heart Atria | 4 | 2018 | 1349 | 0.280 |
Why?
|
Dialysis Solutions | 3 | 2022 | 34 | 0.280 |
Why?
|
Polytetrafluoroethylene | 1 | 2008 | 245 | 0.270 |
Why?
|
Therapy, Computer-Assisted | 1 | 2008 | 265 | 0.270 |
Why?
|
Family Health | 1 | 2011 | 1254 | 0.260 |
Why?
|
Equipment Failure | 1 | 2008 | 580 | 0.260 |
Why?
|
Kidney Failure, Chronic | 4 | 2022 | 2478 | 0.260 |
Why?
|
Sarcoidosis | 2 | 2014 | 537 | 0.260 |
Why?
|
Device Removal | 3 | 2022 | 629 | 0.250 |
Why?
|
Middle Aged | 62 | 2024 | 220858 | 0.250 |
Why?
|
Humans | 100 | 2024 | 761222 | 0.240 |
Why?
|
Cardiac Surgical Procedures | 6 | 2023 | 3627 | 0.230 |
Why?
|
Cicatrix | 4 | 2016 | 793 | 0.230 |
Why?
|
Ventricular Premature Complexes | 2 | 2015 | 112 | 0.220 |
Why?
|
Time Factors | 19 | 2024 | 39957 | 0.210 |
Why?
|
Aged | 46 | 2024 | 169292 | 0.210 |
Why?
|
Endocardium | 1 | 2004 | 248 | 0.210 |
Why?
|
Male | 66 | 2024 | 360703 | 0.210 |
Why?
|
Electric Impedance | 2 | 2024 | 756 | 0.210 |
Why?
|
Tachycardia, Reciprocating | 2 | 2013 | 15 | 0.210 |
Why?
|
Female | 69 | 2024 | 392552 | 0.190 |
Why?
|
Ethanol | 3 | 2015 | 1322 | 0.190 |
Why?
|
Risk Factors | 28 | 2019 | 74241 | 0.190 |
Why?
|
Quality Assurance, Health Care | 1 | 2011 | 2164 | 0.180 |
Why?
|
Chi-Square Distribution | 7 | 2014 | 3418 | 0.180 |
Why?
|
Thallium Radioisotopes | 3 | 1999 | 139 | 0.180 |
Why?
|
Bundle of His | 2 | 2015 | 101 | 0.170 |
Why?
|
Organotechnetium Compounds | 2 | 1999 | 132 | 0.170 |
Why?
|
Recurrence | 13 | 2018 | 8457 | 0.170 |
Why?
|
Myocardium | 3 | 2010 | 4746 | 0.170 |
Why?
|
Lung Transplantation | 1 | 2009 | 1307 | 0.170 |
Why?
|
Prosthesis Implantation | 1 | 2024 | 590 | 0.170 |
Why?
|
Action Potentials | 5 | 2024 | 1830 | 0.170 |
Why?
|
Heart Diseases | 4 | 2019 | 2795 | 0.160 |
Why?
|
Organophosphorus Compounds | 2 | 1999 | 207 | 0.160 |
Why?
|
Pulmonary Veins | 1 | 2024 | 743 | 0.150 |
Why?
|
Coronary Artery Bypass | 1 | 2007 | 2193 | 0.150 |
Why?
|
Long QT Syndrome | 3 | 2018 | 466 | 0.150 |
Why?
|
Rural Population | 2 | 2018 | 2277 | 0.150 |
Why?
|
Atrioventricular Block | 1 | 2018 | 133 | 0.140 |
Why?
|
Heart Defects, Congenital | 2 | 2010 | 4673 | 0.140 |
Why?
|
Needs Assessment | 1 | 2003 | 1141 | 0.140 |
Why?
|
Equipment Design | 5 | 2014 | 3510 | 0.140 |
Why?
|
Heparin | 2 | 2017 | 1632 | 0.140 |
Why?
|
Therapeutic Irrigation | 1 | 2017 | 293 | 0.130 |
Why?
|
Risk Assessment | 11 | 2024 | 24022 | 0.130 |
Why?
|
Myocardial Ischemia | 4 | 2016 | 2133 | 0.130 |
Why?
|
Lamin Type A | 1 | 2016 | 187 | 0.120 |
Why?
|
Heart Valve Diseases | 1 | 2003 | 1031 | 0.120 |
Why?
|
Phrenic Nerve | 1 | 2015 | 79 | 0.120 |
Why?
|
Predictive Value of Tests | 8 | 2018 | 15308 | 0.120 |
Why?
|
Incidence | 12 | 2020 | 21366 | 0.120 |
Why?
|
Tricuspid Atresia | 1 | 2014 | 37 | 0.120 |
Why?
|
Prospective Studies | 12 | 2024 | 54437 | 0.120 |
Why?
|
Medical History Taking | 1 | 2018 | 773 | 0.120 |
Why?
|
Ventricular Septum | 1 | 2015 | 76 | 0.120 |
Why?
|
Heart Valve Prosthesis | 1 | 2003 | 1463 | 0.110 |
Why?
|
Retrospective Studies | 24 | 2024 | 80675 | 0.110 |
Why?
|
Hypotension | 1 | 2020 | 879 | 0.110 |
Why?
|
Brugada Syndrome | 2 | 2012 | 93 | 0.110 |
Why?
|
Cause of Death | 1 | 2024 | 3688 | 0.110 |
Why?
|
Cardiac Resynchronization Therapy Devices | 2 | 2012 | 122 | 0.110 |
Why?
|
Coronary Vessels | 3 | 2014 | 3111 | 0.100 |
Why?
|
Reproducibility of Results | 6 | 2018 | 20118 | 0.100 |
Why?
|
Upper Extremity Deep Vein Thrombosis | 1 | 2012 | 26 | 0.100 |
Why?
|
Heart Valve Prosthesis Implantation | 1 | 2003 | 1555 | 0.100 |
Why?
|
Heart Arrest | 1 | 2022 | 1513 | 0.100 |
Why?
|
Adult | 33 | 2019 | 221120 | 0.100 |
Why?
|
Observer Variation | 1 | 2018 | 2610 | 0.100 |
Why?
|
Algorithms | 3 | 2011 | 14025 | 0.100 |
Why?
|
Education, Medical, Graduate | 1 | 2024 | 2374 | 0.100 |
Why?
|
Heart | 3 | 2007 | 4431 | 0.100 |
Why?
|
Prevalence | 7 | 2019 | 15721 | 0.090 |
Why?
|
Follow-Up Studies | 11 | 2019 | 39127 | 0.090 |
Why?
|
Epicardial Mapping | 3 | 2018 | 58 | 0.090 |
Why?
|
Survival Rate | 7 | 2024 | 12728 | 0.090 |
Why?
|
Ventricular Dysfunction, Left | 2 | 2006 | 2131 | 0.090 |
Why?
|
Treatment Failure | 5 | 2018 | 2643 | 0.090 |
Why?
|
Stomach | 1 | 2015 | 697 | 0.090 |
Why?
|
Radiography, Interventional | 1 | 2018 | 1122 | 0.090 |
Why?
|
Proportional Hazards Models | 7 | 2016 | 12474 | 0.090 |
Why?
|
Fluoroscopy | 1 | 2014 | 947 | 0.090 |
Why?
|
Thromboembolism | 1 | 2017 | 992 | 0.090 |
Why?
|
Quality of Life | 2 | 2011 | 13367 | 0.090 |
Why?
|
Cryosurgery | 1 | 2015 | 474 | 0.090 |
Why?
|
Uganda | 3 | 2019 | 1332 | 0.080 |
Why?
|
Esophagus | 1 | 2015 | 1036 | 0.080 |
Why?
|
International Normalized Ratio | 1 | 2010 | 382 | 0.080 |
Why?
|
Clinical Competence | 1 | 2024 | 4788 | 0.080 |
Why?
|
Intraoperative Complications | 1 | 2015 | 1164 | 0.080 |
Why?
|
Residence Characteristics | 1 | 2018 | 2092 | 0.080 |
Why?
|
Acceleration | 1 | 2008 | 189 | 0.070 |
Why?
|
Population Surveillance | 1 | 2018 | 2598 | 0.070 |
Why?
|
Anti-Bacterial Agents | 2 | 2022 | 7407 | 0.070 |
Why?
|
Echocardiography, Three-Dimensional | 1 | 2013 | 607 | 0.070 |
Why?
|
Transducers | 1 | 2008 | 244 | 0.070 |
Why?
|
Databases, Factual | 2 | 2024 | 7965 | 0.070 |
Why?
|
Syncope | 1 | 2010 | 428 | 0.070 |
Why?
|
Dermatomycoses | 1 | 2007 | 48 | 0.070 |
Why?
|
Coronary Circulation | 3 | 1999 | 1611 | 0.070 |
Why?
|
Registries | 2 | 2024 | 8246 | 0.070 |
Why?
|
Actigraphy | 1 | 2010 | 522 | 0.070 |
Why?
|
Respiratory Mechanics | 1 | 2010 | 698 | 0.070 |
Why?
|
Adrenergic beta-Antagonists | 2 | 2010 | 1241 | 0.070 |
Why?
|
Radiation Dosage | 1 | 2014 | 1962 | 0.070 |
Why?
|
Torsades de Pointes | 1 | 2007 | 77 | 0.070 |
Why?
|
Catheterization, Central Venous | 1 | 2011 | 526 | 0.070 |
Why?
|
Coronary Disease | 3 | 1997 | 5921 | 0.060 |
Why?
|
Heart Valves | 1 | 2007 | 284 | 0.060 |
Why?
|
Coated Materials, Biocompatible | 1 | 2008 | 311 | 0.060 |
Why?
|
Monitoring, Ambulatory | 1 | 2008 | 355 | 0.060 |
Why?
|
Hemorrhage | 2 | 2023 | 3422 | 0.060 |
Why?
|
Body Mass Index | 3 | 2014 | 12952 | 0.060 |
Why?
|
Aspergillosis | 1 | 2007 | 242 | 0.060 |
Why?
|
Vitamin E | 1 | 2009 | 872 | 0.060 |
Why?
|
Cardiac Electrophysiology | 1 | 2024 | 59 | 0.060 |
Why?
|
Blood Coagulation | 1 | 2010 | 1156 | 0.060 |
Why?
|
Drug Monitoring | 1 | 2010 | 961 | 0.060 |
Why?
|
Massachusetts | 3 | 2016 | 8837 | 0.060 |
Why?
|
United States | 9 | 2020 | 72341 | 0.050 |
Why?
|
Sensitivity and Specificity | 4 | 2017 | 14675 | 0.050 |
Why?
|
Disease-Free Survival | 4 | 2018 | 6819 | 0.050 |
Why?
|
Glycopeptides | 1 | 2004 | 220 | 0.050 |
Why?
|
Coronavirus Infections | 1 | 2020 | 3093 | 0.050 |
Why?
|
Boston | 5 | 2016 | 9327 | 0.050 |
Why?
|
Pneumonia, Viral | 1 | 2020 | 3215 | 0.050 |
Why?
|
Learning Curve | 1 | 2024 | 230 | 0.050 |
Why?
|
India | 2 | 2020 | 2287 | 0.050 |
Why?
|
Tetralogy of Fallot | 1 | 2007 | 618 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 4 | 2015 | 6486 | 0.050 |
Why?
|
Angiotensin-Converting Enzyme Inhibitors | 1 | 2009 | 1504 | 0.050 |
Why?
|
Antifungal Agents | 1 | 2007 | 752 | 0.050 |
Why?
|
Myocardial Infarction | 3 | 2013 | 11476 | 0.050 |
Why?
|
Apnea | 1 | 2023 | 195 | 0.050 |
Why?
|
Survival Analysis | 3 | 2012 | 10088 | 0.050 |
Why?
|
Stroke | 1 | 2024 | 9721 | 0.050 |
Why?
|
Triazoles | 1 | 2007 | 902 | 0.050 |
Why?
|
Systole | 2 | 2009 | 936 | 0.050 |
Why?
|
Bradycardia | 1 | 2022 | 298 | 0.050 |
Why?
|
Prognosis | 7 | 2018 | 29688 | 0.050 |
Why?
|
Electrolytes | 1 | 2021 | 274 | 0.040 |
Why?
|
Pandemics | 1 | 2020 | 8663 | 0.040 |
Why?
|
Echocardiography | 2 | 2010 | 5006 | 0.040 |
Why?
|
Bicarbonates | 1 | 2021 | 292 | 0.040 |
Why?
|
Arrhythmogenic Right Ventricular Dysplasia | 2 | 2012 | 162 | 0.040 |
Why?
|
Cohort Studies | 6 | 2010 | 41496 | 0.040 |
Why?
|
Hemodialysis Solutions | 1 | 2019 | 7 | 0.040 |
Why?
|
Anticoagulants | 2 | 2017 | 4795 | 0.040 |
Why?
|
Overweight | 1 | 2010 | 2418 | 0.040 |
Why?
|
Radionuclide Imaging | 3 | 1999 | 1989 | 0.040 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2012 | 2254 | 0.040 |
Why?
|
Aged, 80 and over | 4 | 2024 | 58952 | 0.040 |
Why?
|
Logistic Models | 3 | 2014 | 13249 | 0.040 |
Why?
|
Rural Health | 1 | 2019 | 296 | 0.040 |
Why?
|
Glomerular Filtration Rate | 1 | 2006 | 2182 | 0.040 |
Why?
|
Dogs | 3 | 1999 | 3832 | 0.040 |
Why?
|
Reoperation | 3 | 2015 | 4303 | 0.040 |
Why?
|
Thoracic Surgery | 1 | 2004 | 722 | 0.040 |
Why?
|
Probability | 1 | 2003 | 2478 | 0.040 |
Why?
|
Aspirin | 1 | 2009 | 3129 | 0.040 |
Why?
|
Age Factors | 2 | 2011 | 18384 | 0.040 |
Why?
|
Severity of Illness Index | 3 | 2010 | 15841 | 0.040 |
Why?
|
Purinergic P1 Receptor Agonists | 1 | 1996 | 39 | 0.030 |
Why?
|
Microspheres | 2 | 1999 | 783 | 0.030 |
Why?
|
Biophysical Phenomena | 1 | 2017 | 321 | 0.030 |
Why?
|
Technetium Tc 99m Sestamibi | 1 | 1997 | 183 | 0.030 |
Why?
|
Exercise Test | 2 | 2010 | 2165 | 0.030 |
Why?
|
Premedication | 1 | 2017 | 246 | 0.030 |
Why?
|
Patient Selection | 3 | 2014 | 4246 | 0.030 |
Why?
|
Multivariate Analysis | 2 | 2014 | 12052 | 0.030 |
Why?
|
Fellowships and Scholarships | 1 | 2024 | 1115 | 0.030 |
Why?
|
Patient Education as Topic | 1 | 2005 | 2317 | 0.030 |
Why?
|
Hemodynamics | 3 | 2010 | 4165 | 0.030 |
Why?
|
Practice Guidelines as Topic | 1 | 2012 | 7400 | 0.030 |
Why?
|
Esophageal Perforation | 1 | 2015 | 65 | 0.030 |
Why?
|
Morbidity | 1 | 2020 | 1751 | 0.030 |
Why?
|
Magnetic Resonance Imaging | 2 | 2014 | 36415 | 0.030 |
Why?
|
Sex Factors | 2 | 2024 | 10553 | 0.030 |
Why?
|
Surgical Wound Infection | 1 | 2004 | 1530 | 0.030 |
Why?
|
Administration, Oral | 2 | 2017 | 4015 | 0.030 |
Why?
|
Pyrimidines | 1 | 2007 | 3027 | 0.030 |
Why?
|
Sex Distribution | 1 | 2019 | 2277 | 0.030 |
Why?
|
Research Design | 2 | 2010 | 6180 | 0.030 |
Why?
|
Renal Insufficiency | 1 | 2020 | 808 | 0.030 |
Why?
|
Hospitalization | 2 | 2024 | 10707 | 0.030 |
Why?
|
Comorbidity | 3 | 2017 | 10516 | 0.030 |
Why?
|
Voltage-Sensitive Dye Imaging | 1 | 2013 | 30 | 0.030 |
Why?
|
Esophageal Diseases | 1 | 2015 | 168 | 0.030 |
Why?
|
Preoperative Care | 1 | 2003 | 2241 | 0.030 |
Why?
|
Exercise | 1 | 2010 | 5874 | 0.030 |
Why?
|
Meglumine | 1 | 2014 | 144 | 0.030 |
Why?
|
Ulcer | 1 | 2015 | 204 | 0.030 |
Why?
|
Cardiac-Gated Imaging Techniques | 1 | 2014 | 139 | 0.030 |
Why?
|
Blood Pressure | 1 | 2009 | 8479 | 0.030 |
Why?
|
Laboratories, Hospital | 1 | 2014 | 192 | 0.030 |
Why?
|
Retreatment | 1 | 2014 | 598 | 0.030 |
Why?
|
HIV Infections | 1 | 2019 | 17348 | 0.030 |
Why?
|
Diagnosis, Differential | 3 | 2015 | 12976 | 0.030 |
Why?
|
Sodium | 1 | 2018 | 1589 | 0.030 |
Why?
|
Swine | 2 | 2017 | 5909 | 0.030 |
Why?
|
Adenosine | 1 | 1996 | 805 | 0.020 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 1997 | 1130 | 0.020 |
Why?
|
Vascular System Injuries | 1 | 2014 | 246 | 0.020 |
Why?
|
Organometallic Compounds | 1 | 2014 | 647 | 0.020 |
Why?
|
Causality | 1 | 2017 | 1244 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 2007 | 1376 | 0.020 |
Why?
|
Coronary Angiography | 2 | 2014 | 4507 | 0.020 |
Why?
|
Sotalol | 1 | 2010 | 47 | 0.020 |
Why?
|
Coronary Artery Disease | 1 | 2010 | 6506 | 0.020 |
Why?
|
Cardiac Tamponade | 1 | 2011 | 175 | 0.020 |
Why?
|
Heart Block | 1 | 2011 | 385 | 0.020 |
Why?
|
Artificial Intelligence | 1 | 2024 | 2576 | 0.020 |
Why?
|
Respiratory Rate | 1 | 2010 | 176 | 0.020 |
Why?
|
Hypertension | 1 | 2009 | 8536 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 1999 | 2684 | 0.020 |
Why?
|
Cardiac Imaging Techniques | 1 | 2011 | 278 | 0.020 |
Why?
|
Quality Improvement | 1 | 2024 | 3808 | 0.020 |
Why?
|
Tidal Volume | 1 | 2010 | 488 | 0.020 |
Why?
|
Amiodarone | 1 | 2010 | 217 | 0.020 |
Why?
|
Fontan Procedure | 1 | 2014 | 796 | 0.020 |
Why?
|
Dose-Response Relationship, Drug | 2 | 2017 | 10756 | 0.020 |
Why?
|
Cross-Sectional Studies | 2 | 2018 | 26072 | 0.020 |
Why?
|
Fibrinolytic Agents | 1 | 2017 | 2075 | 0.020 |
Why?
|
Genetic Predisposition to Disease | 1 | 2009 | 17897 | 0.020 |
Why?
|
Drug Therapy, Combination | 1 | 2017 | 6304 | 0.020 |
Why?
|
Statistics, Nonparametric | 1 | 2012 | 2854 | 0.020 |
Why?
|
Diastole | 1 | 2009 | 782 | 0.020 |
Why?
|
Body Weight | 1 | 2017 | 4618 | 0.020 |
Why?
|
Kinetics | 1 | 2013 | 6312 | 0.020 |
Why?
|
Prosthesis Failure | 1 | 2011 | 1204 | 0.020 |
Why?
|
Health Surveys | 1 | 2015 | 4037 | 0.020 |
Why?
|
Mortality | 1 | 2016 | 2896 | 0.010 |
Why?
|
Anthracyclines | 1 | 2007 | 285 | 0.010 |
Why?
|
Calcium | 1 | 2018 | 5719 | 0.010 |
Why?
|
Cardiopulmonary Resuscitation | 1 | 2012 | 991 | 0.010 |
Why?
|
Electrophysiology | 1 | 2007 | 1262 | 0.010 |
Why?
|
Safety Management | 1 | 2010 | 761 | 0.010 |
Why?
|
Anti-HIV Agents | 1 | 2019 | 4527 | 0.010 |
Why?
|
Drug Synergism | 1 | 2007 | 1756 | 0.010 |
Why?
|
Combined Modality Therapy | 1 | 2014 | 8519 | 0.010 |
Why?
|
beta-Lactams | 1 | 2004 | 156 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 2010 | 4851 | 0.010 |
Why?
|
Odds Ratio | 1 | 2014 | 9652 | 0.010 |
Why?
|
Medical Records | 1 | 2007 | 1409 | 0.010 |
Why?
|
Warfarin | 1 | 2010 | 1482 | 0.010 |
Why?
|
Gram-Positive Bacterial Infections | 1 | 2004 | 342 | 0.010 |
Why?
|
Antioxidants | 1 | 2009 | 1667 | 0.010 |
Why?
|
Contrast Media | 1 | 2014 | 5311 | 0.010 |
Why?
|
Regression Analysis | 1 | 2010 | 6345 | 0.010 |
Why?
|
Women's Health | 1 | 2010 | 2070 | 0.010 |
Why?
|
Animals | 5 | 2017 | 168089 | 0.010 |
Why?
|
Disease Progression | 1 | 2016 | 13511 | 0.010 |
Why?
|
Image Processing, Computer-Assisted | 1 | 1996 | 8998 | 0.010 |
Why?
|
Antibiotic Prophylaxis | 1 | 2004 | 637 | 0.010 |
Why?
|
Phenotype | 1 | 2016 | 16575 | 0.010 |
Why?
|
Patient Readmission | 1 | 2012 | 3265 | 0.010 |
Why?
|
Ultrasonography | 1 | 2011 | 5969 | 0.010 |
Why?
|
Myocardial Reperfusion | 1 | 1999 | 339 | 0.010 |
Why?
|
Platelet Aggregation Inhibitors | 1 | 2009 | 2746 | 0.010 |
Why?
|
Double-Blind Method | 1 | 2010 | 12341 | 0.010 |
Why?
|
Feasibility Studies | 1 | 2004 | 5250 | 0.010 |
Why?
|
Death | 1 | 1997 | 677 | 0.010 |
Why?
|
Vasodilator Agents | 1 | 1996 | 989 | 0.010 |
Why?
|
Mutation | 1 | 2016 | 30004 | 0.010 |
Why?
|
Young Adult | 1 | 2018 | 59222 | 0.010 |
Why?
|
Leukemia, Myeloid, Acute | 1 | 2007 | 3610 | 0.010 |
Why?
|
Clinical Trials as Topic | 1 | 2004 | 8002 | 0.000 |
Why?
|
Obesity | 1 | 2010 | 12940 | 0.000 |
Why?
|
Antineoplastic Agents | 1 | 2007 | 13632 | 0.000 |
Why?
|